Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 7/20 | 0.65 |
| ▸ | AHR | P35869 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | HTR2B | P41595 | 2/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.45 |
| ▸ | BCHE | P06276 | 2/20 | 0.44 |
| ▸ | ACHE | P22303 | 2/20 | 0.44 |
| ▸ | NOX1 | Q9Y5S8 | 1/20 | 0.44 |
| ▸ | HTR7 | P34969 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17396556 | 0.90 | AHR (0.58) | ALOX5AHRLMNAHTR2BCHEK1 | |
| SCHEMBL6045366 | 0.89 | ALOX5 (0.65) | ALOX5AHRLMNAHTR2BTP53 | |
| Phenoxazine SCHEMBL7862 | 0.81 | ALOX5 (1.00) | ALOX5LMNAHTR2BMAPTHTR7 | |
| Phenoxazine SCHEMBL29355714 | 0.81 | ALOX5 (1.00) | ALOX5LMNAHTR2BMAPTHTR7 | |
| Phenoxazine SCHEMBL6310178 | 0.81 | ALOX5 (1.00) | ALOX5LMNAHTR2BMAPTHTR7 | |
| Phenoxazine SCHEMBL28844098 | 0.81 | ALOX5 (1.00) | ALOX5LMNAHTR2BMAPTHTR7 | |
| SCHEMBL11536640 | 0.81 | ALOX5 (0.65) | ALOX5AHRLMNAHTR2BTP53 | |
| SCHEMBL18333660 | 0.80 | ALOX5 (0.71) | ALOX5LMNAHTR2BMAPTHTR7 | |
| SCHEMBL7878578 | 0.80 | LMNA (0.73) | ALOX5LMNATP53MAPTCHEK1 | |
| SCHEMBL1366565 | 0.80 | LMNA (0.58) | ALOX5LMNATP53MAPTCHEK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230192719-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT | CANON KABUSHIKI KAISHA (JP) | 2023-06-22 | — | — | US | disclosed |
| US-11524970-B2 | Nitrogen-containing compound, electronic element, and electronic device | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2022-12-13 | — | — | US | disclosed |
| US-11524970-B2 | Nitrogen-containing compound, electronic element, and electronic device | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2022-12-13 | — | — | US | disclosed |
| EP-3347355-B1 | HETEROTRICYCLIC SULFONAMIDES AS ANTI-CANCER AGENTS | ICAHN SCHOOL MED MOUNT SINAI (US) | 2022-07-13 | — | — | EP | disclosed |
| EP-3347355-B1 | HETEROTRICYCLIC SULFONAMIDES AS ANTI-CANCER AGENTS | ICAHN SCHOOL MED MOUNT SINAI (US) | 2022-07-13 | — | — | EP | disclosed |
| US-20220213124-A1 | NITROGEN-CONTAINING COMPOUND, ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2022-07-07 | — | — | US | disclosed |
| US-20220213124-A1 | NITROGEN-CONTAINING COMPOUND, ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2022-07-07 | — | — | US | disclosed |
| CN-108349961-B | Heterocyclic constrained tricyclic sulfonamides as anti-cancer agents | 西奈山伊坎医学院 | 2022-02-18 | — | — | CN | disclosed |
| CN-110903260-B | Nitrogen-containing compound, electronic component, and electronic device | 陕西莱特光电材料股份有限公司 | 2020-11-20 | — | — | CN | disclosed |
| US-10759790-B2 | Heterocyclic constrained tricyclic sulfonamides as anti-cancer agents | ICHAN SCHOOL OF MEDICINE AT MOUNT SINAI (US) | 2020-09-01 | — | — | US | disclosed |
| CN-101043918-A | Cationic azacyanine dyes and colorants containing said dyes | PROCTER & GAMBLE (US) | 2007-09-26 | — | — | CN | disclosed |
| CN-1599591-A | Hair treatment composition comprising composite particles of clay and charged organic molecule | UNILEVER PLC (NL) | 2005-03-23 | — | — | CN | disclosed |
| US-5756356-A | COLORIMETRIC | TOYO INK MANUFACTURING CO., LTD. (JP) | 1998-05-26 | — | — | US | disclosed |
| US-4132794-A | 10-Imidoylacridan compositions | MEAD JOHNSON & COMPANY (US) | 1979-01-02 | — | — | US | disclosed |
| US-4115571-A | DIURETICS, SMOOTH MUSCLE RELAXANTS, ANTITHROMBOGENIC AGENTS | MEAD JOHNSON & COMPANY (US) | 1978-09-19 | — | — | US | disclosed |
| US-4094981-A | SMOOTH MUSCLE RELAXANT EMPLOYING 10-IMIDOYLACRIDANS | MEAD JOHNSON & COMPANY (US) | 1978-06-13 | — | — | US | disclosed |
| US-4077959-A | DIURETICS, SMOOTH MUSCLE RELAXANTS, ANTITHROMBOGENIC | MEAD JOHNSON & COMPANY (US) | 1978-03-07 | — | — | US | disclosed |
| US-4046891-A | Smooth muscle relaxant process employing 10-imidoylphenoxazines | MEAD JOHNSON & COMPANY (US) | 1977-09-06 | — | — | US | disclosed |
| US-3962252-A | 10-IMIDOYLACRIDANS | MEAD JOHNSON & COMPANY (US) | 1976-06-08 | — | — | US | disclosed |
| US-3946004-A | DIURETICS, MUSCLE RELAXANTS, ANTITHROMBOGENIC AGENTS | MEAD JOHNSON & COMPANY (US) | 1976-03-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230192719-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT | OR10J3, CRY1, RPS19 | ALOX5 2723/4885AHR 69/4885LMNA 3557/4885 |
| US-10759790-B2 | Heterocyclic constrained tricyclic sulfonamides as anti-cancer agents | FOXO1, HDAC3, HDAC6 | ALOX5 4631/4885AHR 1441/4885LMNA 3439/4885 |
| US-11524970-B2 | Nitrogen-containing compound, electronic element, and electronic device | OCIAD1, OCIAD2, JUND | ALOX5 672/4885AHR 3188/4885LMNA 2691/4885 |
| US-20220213124-A1 | NITROGEN-CONTAINING COMPOUND, ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE | OCIAD1, OCIAD2, JUND | ALOX5 672/4885AHR 3188/4885LMNA 2691/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.